Supernus Pharmaceuticals Inc Stock Performance
as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
$45.82$47.1
0.43%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
$29.16$57.6536.64%
Downside
25.27%
Upside
Supernus Pharmaceuticals Inc share price movements today
- Previous Close
- $47.27
- Open
- $46.77
- Volume
- 739.2K
- Day's Low - High
- $45.82 - $47.1
- 52 Week Low - High
- $29.16 - $57.65
Supernus Pharmaceuticals Inc Historical Returns
- 1 Month Return
- -4.12 %
- 3 Month Return
- + 11.62 %
- 1 Year Return
- + 25.74 %
- 3 Year Return
- + 32.62 %
- 5 Year Return
- + 95.17 %
Supernus Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Supernus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.6B
EPS (TTM)
5.95
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.11%
PE Ratio (TTM)
368.14
Industry PE ratio
-0.8126129032258065
PEG Ratio
1.47
EBITDA
39.8M
Revenue (TTM)
681.5M
Profit Margin
-2.81%
Return On Equity TTM
-1.86%
Supernus Pharmaceuticals Inc Stock Valuation
Track how Supernus Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Supernus Pharmaceuticals Inc in the last 5 years
Lowest (9.12x)
December 31, 2020
Industry (-0.81x)
November 8, 2025
Today (368.14x)
November 8, 2025
Highest (50.84x)
September 30, 2022
Today’s Price to Earnings Ratio: 368.14x
Supernus Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Supernus Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.6B | 95.17% | 368.14 | -2.81% | |
| BUY | $19.3B | NA | 17.02 | 40.65% | |
| BUY | $41.9B | NA | 21.88 | 13.81% | |
| BUY | $15.4B | 58.16% | 36.95 | 15.95% | |
| BUY | $52.7B | -28.96% | 20.13 | 28.21% |
Stock Returns calculator for Supernus Pharmaceuticals Inc Stock including INR - Dollar returns
The Supernus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Supernus Pharmaceuticals Inc investment value today
Current value as on today
₹1,30,844
Returns
₹30,844
(+30.84%)
Returns from Supernus Pharmaceuticals Inc Stock
₹25,738 (+25.74%)
Dollar Returns*
₹5,107 (+5.11%)
Analyst Recommendation on Supernus Pharmaceuticals Inc Stock
Based on 10 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Supernus Pharmaceuticals Inc. Average target price of $59.33
Supernus Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Supernus Pharmaceuticals Inc.
What analysts predicted
22.43%UPSIDE
Target Price
$59.33
Current Price
$46.02
Analyzed by
10 Analysts
Target
$59.33
Supernus Pharmaceuticals Inc target price $59.33, a slight upside of 22.43% compared to current price of $46.02. According to 10 analysts rating.
Supernus Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Search interest for Supernus Pharmaceuticals Inc Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:183% versus previous 30 day period
Supernus Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Supernus Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Supernus Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Supernus Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Supernus Pharmaceuticals Inc News & Key Events
Today's Timeline - 05 November
Wed, 07:07 PM
-Supernus Pharmaceuticals reports Q3 2025 revenue of $192.1 million, but lowers full-year guidance to $695 million, below analyst estimates.
Wed, 10:56 PM
-Shares of Supernus Pharmaceuticals drop 16.8% after weak full-year forecast overshadows strong Q3 earnings report.
Insights on Supernus Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, SUPN has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, SUPN has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 149.82M → 192.10B (in $), with an average increase of 54.7% per quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, SUPN stock has moved down by -14.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 22.49M → -45.11M (in $), with an average decrease of 300.5% per quarter
About Supernus Pharmaceuticals Inc
| Organisation | Supernus Pharmaceuticals Inc |
| Headquarters | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
| Industry | Health Technology |
| CEO | Mr. Jack A. Khattar M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Supernus Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Taylor Raiford | Senior Vice President of Sales |
Mr. Jack A. Khattar M.B.A. | Founder, President, CEO, Secretary & Director |
Dr. Padmanabh P. Bhatt Ph.D. | Chief Scientific Officer & Senior VP of Intellectual Property |
Dr. Jonathan Rubin M.B.A., M.D. | Senior VP of Research & Development and Chief Medical Officer |
Mr. Kevin T. Anderson Esq. | Compliance Officer |
Dr. Todd Horich M.B.A., Ph.D. | Senior Vice President of Marketing, Commercial Operations & Market Access |
Dr. Bryan A. Roecklein Ph.D. | Senior Vice President of Corporate Development |
Mr. Jeff Bozick | Senior Vice President of Supply Chain |
Mr. Timothy C. Dec | Senior VP & CFO |
Mr. Frank Mottola | Senior VP & Chief Technology Operations Officer |
FAQs
What is Supernus Pharmaceuticals Inc share price today?
Supernus Pharmaceuticals Inc share price today is $46.02 as on at the close of the market. Supernus Pharmaceuticals Inc share today touched a day high of $47.1 and a low of $45.82.
What is the 52 week high and 52 week low for Supernus Pharmaceuticals Inc share?
Supernus Pharmaceuticals Inc share touched a 52 week high of $57.65 on and a 52 week low of $29.16 on . Supernus Pharmaceuticals Inc stock price today i.e. is closed at $46.02,which is 20.17% down from its 52 week high and 57.82% up from its 52 week low.
What is Supernus Pharmaceuticals Inc's market capitalisation today?
Supernus Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Supernus Pharmaceuticals Inc Stock (SUPN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Supernus Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Supernus Pharmaceuticals Inc Shares that will get you 0.0326 shares as per Supernus Pharmaceuticals Inc share price of $46.02 per share as on November 8, 2025 at 2:29 am IST.
What is the minimum amount required to buy Supernus Pharmaceuticals Inc Stock (SUPN) from India?
Indian investors can start investing in Supernus Pharmaceuticals Inc (SUPN) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Supernus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Supernus Pharmaceuticals Inc share’s latest price of $46.02 as on November 8, 2025 at 2:29 am IST, you will get 0.2173 shares of Supernus Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Supernus Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Supernus Pharmaceuticals Inc stock has given 95.17% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?